Call to arrange a consultation
+1 416 777 0888

Pfizer Canada Inc. v. Pharmascience Inc.

Represented Pharmascience in a case pursuant to the Patented Medicine (Notice of Compliance Regulations) in respect of pregabalin. Succeeded on the allegation that the patent in issue was invalid. The decision is reported at 2013 FC 120.

Meet the team